Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,003 public trials 2,033 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

A Trial of Ibrutinib, Lenalidomide and Rituximab for Patients With Relapsed/Refractory Mantle Cell Lymphoma

NCT02460276

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Rigshospitalet Copenhagen, Denmark
  • Helsinki University Hospital Helsinki, Finland
  • Norwegian Radium Hospital Oslo, Norway
  • Lund University Hospital Lund, Sweden
View Trial Details
Completed

Safety & Efficacy Study High Dose Evomela Injection for MA Conditioning in MM Patients With Autologous Transplantation

NCT01660633

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Rush University Medical Center Chicago, Illinois, United States
  • University of Kansas Medical Center Fairway, Kansas, United States
  • University of Massachusetts Worcester, Massachusetts, United States
  • Washington University School of Medicine St Louis, Missouri, United States
View Trial Details
Completed

MAgnetic Resonance Imaging in COeliac Disease

NCT02551289

Conditions
Celiac Disease, Celiac Sprue, Coeliac Disease, +18 more
Locations
  • NIHR Biomedical Research Unit in Gastrointestinal and Liver Diseases at Nottingham University Hospitals NHS Trust and the University of Nottingham Nottingham, United Kingdom
View Trial Details
Completed

Phase 1 Nilotinib in Steroid Dependent/Refractory Chronic Graft Versus Host Disease

NCT01155817

Conditions
Bone Marrow Transplant Failure, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Stanford University School of Medicine Stanford, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
  • Fred Hutchinson Cancer Research Center Seattle, Washington, United States
View Trial Details

Related conditions